Monitorización de la ototoxicidad por cisplatino.
Open Access
- 18 November 2016
- journal article
- research article
- Published by Ediciones Universidad de Salamanca in Revista ORL
- Vol. 9 (1), 9-33
- https://doi.org/10.14201/orl.16774
Abstract
Introduction and objective: The ototoxic damage goes unnoticed to disabling levels, being justified to apply control for its early detection procedures, make it possible to a therapeutic change and if necessary, a speech and auditory rehabilitation. The objective of this study will consist to present Protocol we did at the Hospital Clinico Universitario de Valladolid for the follow-up of the patients treated with cisplatin. Method: Ototoxicity monitoring means serially collect hearing thresholds. It is identified on a visit if hearing has worsened in some ear. The comparison allows to detect the change and indicate if it is significant or not in relation to some criteria. We will also evaluate the occurrence of vestibular damage. As auditory monitoring procedures, we will use high frequency audiometry and acoustic oto-emissions. Results: After giving informed consent and a brief medical history we started with baseline assessment of hearing, prior to treatment, continuing with periodic reviews before each cycle. If any change is detected it is reported to the physician and the patient. To grade the ototoxicity, we apply the Brock and Chang criteria. We maintain post-treatment control. Discussion and conclusion: The incidence of ototoxicity of cisplatin is unknown in our country and it is not possible to predict which patients will experience. The increase in the survival rate for cancer involves improving comorbidity, which in the case of its early ototoxicity supposed to find the best solutions to restore the quality of life of patient's detection.This publication has 19 references indexed in Scilit:
- Development and Validation of a Cisplatin Dose-Ototoxicity ModelJournal of the American Academy of Audiology, 2012
- Severe difficulties with word recognition in noise after platinum chemotherapy in childhood, and improvements with open-fitting hearing-aidsInternational Journal of Audiology, 2011
- Pharmacogenomics of cisplatin-induced ototoxicityPharmacogenomics, 2011
- Evaluation of Audiometric Threshold Shift Criteria for Ototoxicity MonitoringJournal of the American Academy of Audiology, 2010
- Practical Grading System for Evaluating Cisplatin Ototoxicity in ChildrenJournal of Clinical Oncology, 2010
- Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimenIndian Journal of Cancer, 2009
- Ototoxicity From Cisplatin Therapy in Childhood CancerJournal of Pediatric Hematology/Oncology, 2007
- Early Changes in Auditory Function As a Result of Platinum Chemotherapy: Use of Extended High-Frequency Audiometry and Evoked Distortion Product Otoacoustic EmissionsJournal of Clinical Oncology, 2007
- Analysis of counted behaviors in a single-subject design: modeling of hearing-aid intervention in hearing-impaired patients with Alzheimer's disease Análisis del conteo de conductas en un diseño unipersonal: Modelo de intervención con auxiliar auditivo en pacientes hipoacúsicos con enfermedad de AlzheimerInternational Journal of Audiology, 2005
- Cisplatin ototoxicity in children: A practical grading systemMedical and Pediatric Oncology, 1991